New research published in Frontiers in Neurology “reports for the first time a pathway that begins in the gut and ends with a potent pro-inflammatory toxin in brain cells contributing to the development of Alzheimer’s disease (AD).” Dr. Walter J. Lukiw, one of the research leads, explains a potential, simple solution. He explains that “dietary-based approaches to balance the microorganisms in the microbiome may be an attractive means to modify the abundance, speciation, and complexity of enterotoxigenic forms of AD-relevant microbes and their potential for the pathological discharge of highly neurotoxic microbial-derived secretions.” These findings could lead to new diagnostic and therapeutic strategies for Alzheimer’s disease which is the 6th leading cause of death in the US.